Exposure of endothelial cells (ECs) to
hypoxia has separately been shown to induce their angiogenesis or death.
Matrix metalloproteinase (MMP)-2 is associated with EC angiogenesis, although recent studies also implicate this molecule in EC death. We studied the effect of
hypoxia in the absence or presence of
TNF-alpha (characteristic of the inflammatory microenvironment accompanying
hypoxia) on MMP-2 expression and its role in angiogenesis (proliferation, migration, and tube formation) and in the death of primary human umbilical vein endothelial cells (HUVECs).
Hypoxia alone (24-48 h in 0.3% O(2) in the hypoxic chamber) and furthermore, when combined with
TNF-alpha, significantly enhanced MMP-2 expression and activity.
Hypoxia also led to a reduction in membrane type 1
MMP (MT1-MMP) and
tissue inhibitor of metalloproteinase-2 mRNA and
protein while enhancing the expression of alpha(v)
beta(3) integrin and the cytoskeletal
protein phosphopaxillin. Moreover,
hypoxia led to colocalization of alpha(v)beta(3) and MMP-2, but not
MT1-MMP, with phosphopaxillin in ECs. These results suggest MT1-MMP-independent activation of MMP-2 during
hypoxia and support interactions between the ECM,
integrins, and the cytoskeleton in
hypoxia-induced MMP-2-related functions.
Hypoxia enhanced EC migration in an MMP-2-dependent manner while leading to a reduction of cell number via their apoptosis, which was also dependent on MMP-2. In addition,
hypoxia caused an aberrant tubelike formation on
Matrigel that appeared to be unaffected by MMP-2. The
hypoxia-induced, MMP-2-dependent migration of ECs is in accordance with the proangiogenic role ascribed to MMP-2, while the involvement of this
protease in the
hypoxia-related death of ECs supports an additional apoptotic role for this
protease. Hence, in the hypoxic microenvironment, MMP-2 appears to have a dual autocrine role in determining the fate of ECs.